Skip to content

Oruka Therapeutics, Inc. ORKA Deferred Tax Assets Lease Liabilities

Deferred Tax Assets Lease Liabilities at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$13.73M-2.6%
Community Financial System logo
Community Financial SystemCBU
$14.35M+15.5%
Celcuity logo
CelcuityCELC
-$12K+75.0%
Moelis & Company logo
Moelis & CompanyMC
$61.34M+20.4%
CHE
ChemedCHE
$34.61M+1.9%
JAN
Janus Living JAN
$33K

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept orka:DeferredTaxAssetsLeaseLiabilities.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s deferred tax assets lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s deferred tax assets lease liabilities?
Oruka Therapeutics, Inc. (ORKA) reported deferred tax assets lease liabilities of $448K in Q4 2025.
What does deferred tax assets lease liabilities mean?
This metric captures the deferred tax asset arising from the temporary difference between the accounting treatment of lease liabilities and their tax basis. It reflects the future tax deductions expected as lease obligations are settled over time. Monitoring this helps investors understand the tax impact of the company's real estate and equipment leasing strategy on its balance sheet.